Re: Cancer research derailed by nearly two years due to COVID-19, scientists say.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Cancer research derailed by nearly two years due to COVID-19, scientists say.

in response to

Cancer research derailed by nearly two years due to COVID-19, scientists say.

10-41

posted on Apr 26, 2021 05:58PM

seems like Zen 3694 trials are going full steam ahead, even with the pandemic going on as per the past news release with the co development deal with Astrella , one has to think one of the BP 's involved will take the risk and buy the whole thing or maybe a few BP will buy together, to minimize their risk .

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply